CA Stock MarketDetailed Quotes

Pharmala Biotech Holdings Inc (MDMA)

Watchlist
  • 0.100
  • 0.0000.00%
15min DelayMarket Closed Apr 17 15:59 ET
10.89MMarket Cap-5.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharmala Biotech Holdings Inc (MDMA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
Total revenue
260.30%206.44K
-41.51%605.5K
223.36%267.38K
-6.48%135.17K
161.97%145.66K
-92.39%57.3K
94.60%1.04M
-81.15%82.69K
144.54K
-40.43%55.6K
Operating revenue
260.30%206.44K
-41.51%605.5K
223.36%267.38K
-6.48%135.17K
161.97%145.66K
-92.39%57.3K
94.60%1.04M
-81.15%82.69K
--144.54K
-40.43%55.6K
Cost of revenue
34.84K
-64.04%53.16K
122.83%34.04K
140.23%9.62K
9.5K
0
89.79%147.86K
-291.40%-149.11K
4K
0
Gross profit
199.50%171.6K
-37.76%552.34K
0.67%233.34K
-10.66%125.55K
144.88%136.15K
-87.53%57.3K
95.43%887.44K
-35.75%231.79K
140.54K
-40.43%55.6K
Operating expense
2.89%515.25K
75.75%2.69M
38.61%617.55K
16.04%642.51K
234.29%929.89K
97.46%500.77K
25.80%1.53M
63.94%445.55K
63.45%553.69K
-10.62%278.17K
Selling and administrative expenses
3.69%411.05K
76.70%2.12M
66.10%460.17K
-11.22%483.17K
287.08%780.37K
123.97%396.42K
4.15%1.2M
-21.79%277.04K
81.37%544.22K
-17.05%201.61K
-General and administrative expense
3.69%411.05K
76.70%2.12M
66.10%460.17K
-11.22%483.17K
287.08%780.37K
123.97%396.42K
4.15%1.2M
-21.79%277.04K
81.37%544.22K
-17.05%201.61K
Research and development costs
23.60%41.1K
94.70%243.94K
-40.54%44.91K
417.07%76.34K
178.01%89.43K
-20.20%33.25K
175.24%125.29K
145.36%75.53K
---24.08K
--32.17K
Depreciation amortization depletion
0.64%29.76K
66.71%117.05K
27.69%29.19K
84.86%29.17K
84.57%29.12K
87.23%29.57K
33.06%70.21K
72.79%22.86K
19.73%15.78K
19.72%15.78K
-Depreciation and amortization
0.64%29.76K
66.71%117.05K
27.69%29.19K
84.86%29.17K
84.57%29.12K
87.23%29.57K
33.06%70.21K
72.79%22.86K
19.73%15.78K
19.72%15.78K
Other operating expenses
-19.73%33.35K
54.53%209.62K
18.78%83.28K
203.00%53.84K
8.21%30.97K
116.87%41.54K
-24.09%135.65K
-1.00%70.11K
-30.31%17.77K
-47.98%28.62K
Operating profit
22.51%-343.65K
-232.27%-2.14M
-79.75%-384.22K
-25.13%-516.97K
-256.63%-793.74K
-315.38%-443.48K
15.65%-643.57K
-340.19%-213.76K
-21.97%-413.15K
-2.15%-222.57K
Net non-operating interest income (expenses)
Other net income (expenses)
-85.36%-66.05K
79.53%-36.85K
317.76%23.08K
-7.27K
-17.03K
78.97%-35.63K
-967.60%-180.03K
93.74%-10.6K
Special income (charges)
-85.36%-66.05K
-123.28%-50.46K
72.81%-6.14K
---8.69K
--0
---35.63K
-34.02%-22.6K
---22.6K
--0
--0
-Less:Other special charges
85.36%66.05K
--35.63K
--0
----
----
--35.63K
----
----
----
----
-Less:Write off
----
-34.38%14.83K
-72.81%6.14K
--8.69K
----
----
34.02%22.6K
--22.6K
--0
----
Other non-operating income (expenses)
----
119.46%30.64K
143.56%29.23K
--1.42K
----
----
---157.43K
--12K
----
----
Income before tax
14.49%-409.7K
-164.12%-2.18M
-60.97%-361.13K
-26.89%-524.24K
-264.28%-810.77K
-1,413.46%-479.11K
-5.61%-823.6K
-179.39%-224.36K
-21.97%-413.15K
-207.97%-222.57K
Income tax
Earnings from equity interest net of tax
Net income
14.49%-409.7K
-164.12%-2.18M
-60.97%-361.13K
-26.89%-524.24K
-264.28%-810.77K
-1,413.46%-479.11K
-5.61%-823.6K
-179.39%-224.36K
-21.97%-413.15K
-207.97%-222.57K
Net income continuous operations
14.49%-409.7K
-164.12%-2.18M
-60.97%-361.13K
-26.89%-524.24K
-264.28%-810.77K
-1,413.46%-479.11K
-5.61%-823.6K
-179.39%-224.36K
-21.97%-413.15K
-207.97%-222.57K
Noncontrolling interests
Net income attributable to the company
14.49%-409.7K
-164.12%-2.18M
-60.97%-361.13K
-26.89%-524.24K
-264.28%-810.77K
-1,413.46%-479.11K
-5.61%-823.6K
-179.39%-224.36K
-21.97%-413.15K
-207.97%-222.57K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
14.49%-409.7K
-164.12%-2.18M
-60.97%-361.13K
-26.89%-524.24K
-264.28%-810.77K
-1,413.46%-479.11K
-5.61%-823.6K
-179.39%-224.36K
-21.97%-413.15K
-207.97%-222.57K
Diluted earnings per share
0.00%-0.01
-100.00%-0.02
0
0
-0.01
-0.01
0.00%-0.01
0
0
0
Basic earnings per share
0.00%-0.01
-100.00%-0.02
0
0
-0.01
-0.01
0.00%-0.01
0
0
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024
Total revenue 260.30%206.44K-41.51%605.5K223.36%267.38K-6.48%135.17K161.97%145.66K-92.39%57.3K94.60%1.04M-81.15%82.69K144.54K-40.43%55.6K
Operating revenue 260.30%206.44K-41.51%605.5K223.36%267.38K-6.48%135.17K161.97%145.66K-92.39%57.3K94.60%1.04M-81.15%82.69K--144.54K-40.43%55.6K
Cost of revenue 34.84K-64.04%53.16K122.83%34.04K140.23%9.62K9.5K089.79%147.86K-291.40%-149.11K4K0
Gross profit 199.50%171.6K-37.76%552.34K0.67%233.34K-10.66%125.55K144.88%136.15K-87.53%57.3K95.43%887.44K-35.75%231.79K140.54K-40.43%55.6K
Operating expense 2.89%515.25K75.75%2.69M38.61%617.55K16.04%642.51K234.29%929.89K97.46%500.77K25.80%1.53M63.94%445.55K63.45%553.69K-10.62%278.17K
Selling and administrative expenses 3.69%411.05K76.70%2.12M66.10%460.17K-11.22%483.17K287.08%780.37K123.97%396.42K4.15%1.2M-21.79%277.04K81.37%544.22K-17.05%201.61K
-General and administrative expense 3.69%411.05K76.70%2.12M66.10%460.17K-11.22%483.17K287.08%780.37K123.97%396.42K4.15%1.2M-21.79%277.04K81.37%544.22K-17.05%201.61K
Research and development costs 23.60%41.1K94.70%243.94K-40.54%44.91K417.07%76.34K178.01%89.43K-20.20%33.25K175.24%125.29K145.36%75.53K---24.08K--32.17K
Depreciation amortization depletion 0.64%29.76K66.71%117.05K27.69%29.19K84.86%29.17K84.57%29.12K87.23%29.57K33.06%70.21K72.79%22.86K19.73%15.78K19.72%15.78K
-Depreciation and amortization 0.64%29.76K66.71%117.05K27.69%29.19K84.86%29.17K84.57%29.12K87.23%29.57K33.06%70.21K72.79%22.86K19.73%15.78K19.72%15.78K
Other operating expenses -19.73%33.35K54.53%209.62K18.78%83.28K203.00%53.84K8.21%30.97K116.87%41.54K-24.09%135.65K-1.00%70.11K-30.31%17.77K-47.98%28.62K
Operating profit 22.51%-343.65K-232.27%-2.14M-79.75%-384.22K-25.13%-516.97K-256.63%-793.74K-315.38%-443.48K15.65%-643.57K-340.19%-213.76K-21.97%-413.15K-2.15%-222.57K
Net non-operating interest income (expenses)
Other net income (expenses) -85.36%-66.05K79.53%-36.85K317.76%23.08K-7.27K-17.03K78.97%-35.63K-967.60%-180.03K93.74%-10.6K
Special income (charges) -85.36%-66.05K-123.28%-50.46K72.81%-6.14K---8.69K--0---35.63K-34.02%-22.6K---22.6K--0--0
-Less:Other special charges 85.36%66.05K--35.63K--0----------35.63K----------------
-Less:Write off -----34.38%14.83K-72.81%6.14K--8.69K--------34.02%22.6K--22.6K--0----
Other non-operating income (expenses) ----119.46%30.64K143.56%29.23K--1.42K-----------157.43K--12K--------
Income before tax 14.49%-409.7K-164.12%-2.18M-60.97%-361.13K-26.89%-524.24K-264.28%-810.77K-1,413.46%-479.11K-5.61%-823.6K-179.39%-224.36K-21.97%-413.15K-207.97%-222.57K
Income tax
Earnings from equity interest net of tax
Net income 14.49%-409.7K-164.12%-2.18M-60.97%-361.13K-26.89%-524.24K-264.28%-810.77K-1,413.46%-479.11K-5.61%-823.6K-179.39%-224.36K-21.97%-413.15K-207.97%-222.57K
Net income continuous operations 14.49%-409.7K-164.12%-2.18M-60.97%-361.13K-26.89%-524.24K-264.28%-810.77K-1,413.46%-479.11K-5.61%-823.6K-179.39%-224.36K-21.97%-413.15K-207.97%-222.57K
Noncontrolling interests
Net income attributable to the company 14.49%-409.7K-164.12%-2.18M-60.97%-361.13K-26.89%-524.24K-264.28%-810.77K-1,413.46%-479.11K-5.61%-823.6K-179.39%-224.36K-21.97%-413.15K-207.97%-222.57K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 14.49%-409.7K-164.12%-2.18M-60.97%-361.13K-26.89%-524.24K-264.28%-810.77K-1,413.46%-479.11K-5.61%-823.6K-179.39%-224.36K-21.97%-413.15K-207.97%-222.57K
Diluted earnings per share 0.00%-0.01-100.00%-0.0200-0.01-0.010.00%-0.01000
Basic earnings per share 0.00%-0.01-100.00%-0.0200-0.01-0.010.00%-0.01000
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -